Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
JTL Industries subsidiary doubles HR coil capacity with ₹15 crore capex
20+ min ago (612+ words) JTL Industries has announced that its subsidiary, JTL Engineering Limited, will undertake a capital expenditure of approximately ₹15 crore to expand its narrow-width hot-rolled (HR) coil manufacturing capacity. The investment aims to double the monthly production volume and enhance product width…...
Inside the Tk309cr engineering industrial park where no factories exist
22+ min ago (1090+ words) Monday August 24, 2026 The Bangladesh Small and Cottage Industries Corporation (BSCIC) has failed to allocate all its plots in the Tk300-crore industrial park in Munshiganj even four years after the completion of the project. The plan was to move the lathes,…...
NSW extends government media contract again - AdNews
3+ hour, 48+ min ago (184+ words) Credit: Markus Winkler via Unsplash OMD has secured another one-year extension to its NSW Government media account, taking the contract through to September 2027, AdNews can reveal. The account, last valued about $70 million a year, covers media planning, strategy and buying…...
eXoZymes awarded $2M NIH grant to advance cannabinoid analogs
10+ hour, 13+ min ago (283+ words) eXoZymes Inc. received a $2,028,518 Phase IIB SBIR grant from the NIH to advance cannabinoid analogs for drug discovery. The two-year project, beginning July 1, 2026, aims to develop proprietary enzyme-based manufacturing technologies. This award increases the company's total non-dilutive funding to $19.7 million....
Certain Warrants of ProQR Therapeutics N.V. are subject to a Lock-Up Agreement Ending on 24-AUG-2026.
1+ hour, 14+ min ago (158+ words) marketscreener.com Certain Warrants of ProQR Therapeutics N.V are subject to a Lock-Up Agreement Ending on 24-AUG-2026 These Warrants will be under lockup for 60 days starting from 25-JUN-2026 to 24-AUG-2026.Details:The officers and directors have agreed that, during the…...
Celltrion and Samsung Bioepis are in full swing over the biosimilar (biopharmaceutical generic drug).. - MK
56+ min ago (520+ words) Celltrion and Samsung Bioepis are in full swing over the biosimilar (biopharmaceutical generic drug) market of the blockbuster immuno-cancer drug Keytruda, which recorded $31.7 billion (about 44 trillion won) in global sales last year. Celltrion announced on the 24th that it has applied…...
The 10 States Selling the Most Marijuana in 2026, Led by California, Michigan and Florida
1+ hour, 6+ min ago (1061+ words) The Marijuana Herald - Marijuana news and information Legal marijuana sales continue to generate billions of dollars every month across the United States, but a relatively small number of states account for much of the country’s regulated market. Nationwide legal marijuana…...
Sportswear brands turn to supply chains to protect margins
1+ hour, 16+ min ago (419+ words) Outdoor activities and women’s sports are set to support regional demand. Sportswear brands are turning to demand forecasting, tighter product ranges, and diversified sourcing to curb excess inventory and offset pressure from higher costs as shoppers resist price increases, analysts…...
AI adoption could unlock billions for manufacturers - Dangote executive
1+ hour, 50+ min ago (810+ words) Artificial intelligence could unlock billions of dollars in economic value for Africa’s manufacturing sector, but companies must first address weaknesses in data, infrastructure, energy and technical skills, according to the Chief Information Officer of Dangote Cement, Ian Leslie. The executive…...
Celltrion announced on the 24th that it has applied to the Ministry of Food and Drug Safety for dome.. - MK
58+ min ago (238+ words) Celltrion announced on the 24th that it has applied to the Ministry of Food and Drug Safety for domestic product approval of CT-P51, a biosimilar of Keytruda (component name Pembrolizumab), the No. 1 immune anticancer drug in global sales. The authorization application…...